In Nov. 2020, the federal government of Australia signed a contract with Australian biomedical firm CSL to manufacture 50 million doses of the Oxford-AstraZeneca vaccine at the company’s main manufacturing hub in Melbourne.

“Obviously we don’t want to manufacture something that’s not going to be utilized, and we will have a number of options moving into the future,” says Paul Griffin, an associate professor from the University of Queensland. “It obviously has received a lot of negative press.”

https://www.newstarget.com/2021-10-14-australia-shuts-down-manufacturing-astrazeneca-vaccine.html